Mesenteric panniculitis is a rare chronic inflammatory and fibrotic process affecting the adipose tissue of the small bowel mesentery. Although its etiology is not fully understood, autoimmune mechanisms, trauma, surgery, ischemia, and infection have been proposed as triggering factors. It is histologically classified into three stages: mesenteric lipodystrophy (fat necrosis predominant), mesenteric panniculitis (inflammation predominant), and retractile mesenteritis (fibrosis predominant). On CT, diffusely increased density and haziness in the mesentery (misty mesentery) with a surrounding fat halo (fat ring sign) and tumoral pseudocapsule are pathognomonic findings. The disease is more common in males aged 50-70 and is often detected incidentally. Symptomatic cases may present with abdominal pain, fever, weight loss, and bowel obstruction.
Age Range
40-75
Peak Age
55
Gender
Male predominant
Prevalence
Uncommon
Mesenteric panniculitis is a process that begins in mesenteric adipose tissue and progresses through three sequential histological stages. In the first stage (mesenteric lipodystrophy), fat cells undergo necrosis with accumulation of lipid-laden macrophages (foamy histiocytes); CT shows mildly increased density in the mesentery. In the second stage (mesenteric panniculitis), lymphocytes and plasma cells form a dominant inflammatory infiltrate; CT demonstrates 'misty mesentery' — homogeneous haziness above water density but below soft tissue density. In the third stage (retractile mesenteritis), fibrosis predominates with retraction and mass effect around mesenteric vessels and bowel loops; CT shows mass-like soft tissue density in the mesentery with traction on surrounding structures. The fat ring sign — preserved fat halo around mesenteric vessels — indicates that the inflammatory process does not directly involve the vessel wall and is critical for differentiating from lymphoma. The tumoral pseudocapsule is a fibrotic band separating the inflammatory tissue from surrounding normal fat.
Preserved ring of normal fat density around mesenteric vessels. While surrounding mesenteric fat has increased density due to inflammation, perivascular fat maintains its normal density. This finding is the most critical sign for differentiating from lymphoma.
Diffusely increased density in the mesentery on portal venous phase (-40 to -60 HU, normal mesenteric fat -100 to -130 HU). Mesenteric fat becomes homogeneously hazy and loses its normal fat density. This appearance results from increased density of adipose tissue due to inflammatory cell infiltration and edema. Misty mesentery alone is not specific — it can also be seen in pancreatitis, lymphoma, carcinomatosis, and heart failure; however, its association with fat ring sign and pseudocapsule strengthens the diagnosis of mesenteric panniculitis.
Report Sentence
Diffusely increased density and haziness in the mesentery (misty mesentery) is observed, consistent with mesenteric panniculitis.
Preserved fat halo visible around mesenteric vessels and lymph nodes. While the inflammatory process diffusely affects mesenteric fat, perivascular fat tissue is preserved and maintains normal fat density. This finding is an important differential diagnostic criterion from lymphoma encasing vessels because lymphoma does not show preserved fat halo around vessels. Fat ring sign is detected in 50-75% of mesenteric panniculitis cases.
Report Sentence
Preserved fat halo around mesenteric vessels (fat ring sign) is observed, which is pathognomonic for mesenteric panniculitis and important for excluding lymphoma.
Thin, smooth-contoured soft tissue density band (pseudocapsule) surrounding the inflammatory mesenteric tissue. This fibrotic capsule separates the inflammatory process from surrounding normal mesenteric fat and creates a well-defined mass appearance. Pseudocapsule thickness is usually 1-3 mm and may show mild enhancement after contrast administration. In the retractile mesenteritis stage, the pseudocapsule may be more prominent and thickened.
Report Sentence
A thin pseudocapsule surrounding the inflammatory mesenteric tissue is observed, consistent with mesenteric panniculitis.
Small reactive lymph nodes at the mesenteric root and within the inflammatory area (short axis usually <10 mm). Lymph nodes show homogeneous enhancement without necrosis or conglomerate formation. Lymphadenopathy accompanies mesenteric panniculitis in 30-50% of cases and is generally mild. In the presence of large (>15 mm) or necrotic lymph nodes, alternative diagnoses such as lymphoma or metastasis should be considered.
Report Sentence
Small reactive lymph nodes at the mesenteric root are observed, consistent with reactive lymphadenopathy accompanying mesenteric panniculitis.
Heterogeneous hyperintense signal in the mesentery with loss of normal fat signal on T2-weighted images. T2 signal intensity is high in the inflammatory stage (active panniculitis); T2 hypointensity predominates in the fibrotic stage (retractile mesenteritis). On fat-suppressed sequences, the inflammatory area becomes more conspicuous because surrounding normal fat signal is suppressed while inflammatory tissue remains hyperintense. MRI evaluates inflammation activity better than CT.
Report Sentence
Heterogeneous hyperintense infiltration in the mesentery on T2-weighted images is observed, consistent with active mesenteric panniculitis.
Moderate diffusion restriction in active inflammatory areas on diffusion-weighted imaging (DWI). ADC values are lower compared to normal fat tissue in the inflammatory stage. Diffusion restriction reflects inflammation activity and can be used for monitoring treatment response. In the presence of marked diffusion restriction, malignant pathologies such as lymphoma should be excluded.
Report Sentence
Moderate diffusion restriction in the inflammatory area of the mesentery on diffusion-weighted imaging is detected, consistent with active inflammation.
Hyperechoic solid mass-like area in the mesentery on B-mode ultrasonography. Increased homogeneous or heterogeneous echogenicity is seen due to mesenteric fat infiltration. The mass is usually well-defined and surrounds bowel loops but luminal obstruction is rare. US evaluation may be limited in obese patients and deep mesenteric locations; CT is the preferred modality for diagnosis.
Report Sentence
Hyperechoic solid mass-like area in the mesentery on ultrasonography is observed, which may be consistent with mesenteric panniculitis; contrast-enhanced CT is recommended for definitive diagnosis.
Criteria
Fat necrosis predominant stage — macrophage infiltration and foamy histiocytes; mild density increase on CT, usually asymptomatic
Distinct Features
Mildest form; minimal density increase on CT, pseudocapsule and fat ring sign may not yet be prominent
Criteria
Inflammation predominant stage — lymphocyte and plasma cell infiltration; prominent misty mesentery, fat ring sign and pseudocapsule on CT
Distinct Features
Classic triad most prominent: misty mesentery + fat ring sign + pseudocapsule; most symptomatic cases are in this stage
Criteria
Fibrosis predominant stage — dense collagen accumulation; mass-like fibrotic tissue in mesentery, potential for bowel loop retraction and obstruction
Distinct Features
Soft tissue density mass in mesentery on CT; low signal on T2; bowel loop traction and stenosis; requires differentiation from desmoid tumor
Distinguishing Feature
Sclerosing mesenteritis is the fibrosis-predominant subtype of mesenteric panniculitis showing more prominent mass effect and bowel obstruction; panniculitis term generally covers the entire spectrum
Distinguishing Feature
Peritoneal mesothelioma presents with nodular peritoneal thickening and ascites; unlike mesenteric panniculitis, omental cake and peritoneal implants are seen; asbestos exposure history is critical
Distinguishing Feature
Primary peritoneal carcinoma shows dominant ascites, peritoneal implants and omental cake; unlike mesenteric panniculitis, CA-125 elevation and peritoneal nodularity are seen
Distinguishing Feature
Peritoneal TB shows loculated ascites, omental thickening and rim-enhancing lymph nodes; ascites and rim-enhancing lymph nodes are not expected in mesenteric panniculitis; TB exposure and PPD test are differentiating
Urgency
routineManagement
conservativeBiopsy
Not NeededFollow-up
6-monthMesenteric panniculitis is a benign and self-limited process in most cases. No treatment is needed in asymptomatic cases; 6-month CT follow-up is sufficient for stability control. In symptomatic cases, corticosteroids, colchicine, or tamoxifen may be used. Association with malignancy (6-30%) has been reported; lymphoma screening should particularly be considered.
Mesenteric panniculitis is generally a self-limiting benign condition. CT diagnosis prevents unnecessary biopsy and surgery. NSAIDs or short-course steroids may be used in symptomatic patients.